PolyMedica shares soar as SEC (US Securities and Exchange Committee) ends inquiry
This article was originally published in Clinica
Executive Summary
Shares in PolyMedica leapt by over 50% to around $39 after the US Securities and Exchange Committee (SEC) ended an inquiry into the company. However, the company is still the subject of an investigation by the Department of Justice.